Statin
Statins (formally classified as 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, or HMG-CoA reductase inhibitors) are a class of lipid-lowering agents that competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway responsible for endogenous cholesterol biosynthesis.
Statins (formally classified as 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, or HMG-CoA reductase inhibitors) are a class of lipid-lowering agents that competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway responsible for endogenous cholesterol biosynthesis. By blocking this enzymatic step, statins reduce hepatic cholesterol production and upregulate low-density lipoprotein (LDL) receptor expression on hepatocytes, thereby lowering circulating LDL cholesterol and reducing the risk of atherosclerotic cardiovascular disease. First approved for clinical use in the late 1980s, statins have become among the most widely prescribed drugs globally and are considered a cornerstone of primary and secondary cardiovascular prevention. Common members of this drug class include atorvastatin and simvastatin, which differ in their lipophilicity, potency, and metabolic profiles — properties that influence both their efficacy and their safety signatures across organ systems.
Beyond their canonical cholesterol-lowering mechanism, statins exhibit a range of pleiotropic effects — including anti-inflammatory, immunomodulatory, and antioxidant activities — that are only partially explained by reductions in LDL cholesterol or modulation of the mevalonate pathway. These additional biological actions have positioned statins as candidate therapies or adjuncts in a growing number of disease contexts beyond cardiovascular disease, including oncology, liver disease, neurological conditions, and inflammatory disorders. Their broad biological footprint, however, also underlies a spectrum of adverse effects and drug interactions that continue to be characterized in large-scale clinical and genetic studies.
Where the papers sit
13 papers from the last 6 months study statin directly · updated from PubMed 11 Nov 2026
Study type 2 clinical trials · 7 observational · 2 human data · 1 preclinical · 1 unclassified
Themes 3 themes
-
Statin Use in Cardiovascular Prevention
Statin treatment is being pushed toward better prevention in older and high-risk patients, while adherence and tolerability remain limiting factors. Trials address cardiovascular outcomes after primary prevention, intensive therapy after ischemic stroke, and refill support for low adherence. Cognitive testing is generally reassuring, but uncommon neuropathic symptoms remain part of safety monitoring. Hypertension, diabetes, and older age recur as settings requiring individualized benefit–risk assessment.
6 papers · 46.2%
-
Cholesterol Biology and Therapy
Cholesterol metabolism is being treated as both a therapeutic target and a regulator of tumor-cell behavior. In melanoma, cholesterol-dependent PIEZO1 activation supports amoeboid migration, making cholesterol import and biosynthesis potential intervention points. Statin–ezetimibe combinations are being explored with transcriptomic and Boolean models, while broader lipid therapies are being compared in diabetes. The direction is toward combination and mechanism-guided treatment, although much of the evidence remains modeled, preclinical, or protocol-based.
3 papers · 23.1%
-
Others — Statin Outcomes Across Diseases
Statin exposure is being evaluated through outcome associations across unrelated clinical settings rather than a single disease program. Observational analyses link treatment with progression and survival in primary biliary cholangitis, pancreatic cancer outcomes, and dementia risk with antihypertensive combinations. Pregnancy data focus on fetal and maternal outcomes after first-trimester exposure. Cox models and propensity matching recur, but heterogeneous populations and confounding leave causal effects unresolved.
4 papers · 30.8%
Papers
The 13 papers from the last 6 months that study statin directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Statin Use in Cardiovascular Prevention (6)
- Cognitive safety of statin use in the elderly: Evidence from a nationally representative sample. Journal of internal medicine · 8 Sept 2026 PMID 42706500
- Digital Outreach to Improve Statin Refills in Patients With Low Statin Adherence: The ADHERE-ASCVD Randomized Clinical Trial. JAMA · 29 Aug 2026 PMID 42667613
- An uncommon side effect of statins: perioral neuropathic symptoms. BMJ case reports · 24 Aug 2026 PMID 42637515
- Statin adherence among patients with hypertension in Swedish primary health care: a QregPV cohort study using explainable machine learning. European heart journal. Cardiovascular pharmacotherapy · 29 Jun 2026 PMID 42366593
- Dual Antiplatelet Therapy and Immediate Intensive Statin in Mild Ischemic Stroke: A Randomized Trial. Neurology · 25 Jun 2026 PMID 42348803
- Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study. PLoS medicine · 24 Jun 2026 PMID 42340940
Cholesterol Biology and Therapy (3)
- Targeting cholesterol-dependent Piezo1 activation impairs amoeboid migration in melanoma cells. Proceedings of the National Academy of Sciences of the United States of America · 9 Sept 2026 PMID 42715085
- Deciphering the Mechanisms of Statin-Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data. CPT: pharmacometrics & systems pharmacology · 1 Sept 2026 PMID 42678094
- Lipid-modifying pharmacotherapy in diabetes mellitus: A protocol for a systematic review and network meta-analysis of randomised trials. PloS one · 23 Jul 2026 PMID 42490696
Others — Statin Outcomes Across Diseases (4)
- Statins are associated with decreased risk of disease progression and death in non-cirrhotic patients with primary biliary cholangitis. European journal of internal medicine · 3 Oct 2026 PMID 42829287
- Pregnancy Outcome After First-Trimester Exposure to Statins: Study Results Based on the Embryotox Cohort. Pharmacoepidemiology and drug safety · 28 Sept 2026 PMID 42803717
- Impact of β-Blockers, Statins, and Cholinergic Agents on Clinical Outcomes in Pancreatic Cancer: A Retrospective VA Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 18 Aug 2026 PMID 42611506
- Dementia Risk With Combined Statin and Antihypertensive Drugs That Increase Versus Decrease Angiotensin-II Formation: Findings From the 45 and Up Study. International journal of geriatric psychiatry · 29 Jul 2026 PMID 42522377
By study type
Clinical trials (2)
- Digital Outreach to Improve Statin Refills in Patients With Low Statin Adherence: The ADHERE-ASCVD Randomized Clinical Trial. JAMA · 29 Aug 2026 PMID 42667613
- Dual Antiplatelet Therapy and Immediate Intensive Statin in Mild Ischemic Stroke: A Randomized Trial. Neurology · 25 Jun 2026 PMID 42348803
Observational studies and case reports (7)
- Pregnancy Outcome After First-Trimester Exposure to Statins: Study Results Based on the Embryotox Cohort. Pharmacoepidemiology and drug safety · 28 Sept 2026 PMID 42803717
- Cognitive safety of statin use in the elderly: Evidence from a nationally representative sample. Journal of internal medicine · 8 Sept 2026 PMID 42706500
- An uncommon side effect of statins: perioral neuropathic symptoms. BMJ case reports · 24 Aug 2026 PMID 42637515
- Impact of β-Blockers, Statins, and Cholinergic Agents on Clinical Outcomes in Pancreatic Cancer: A Retrospective VA Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 18 Aug 2026 PMID 42611506
- Dementia Risk With Combined Statin and Antihypertensive Drugs That Increase Versus Decrease Angiotensin-II Formation: Findings From the 45 and Up Study. International journal of geriatric psychiatry · 29 Jul 2026 PMID 42522377
- Statin adherence among patients with hypertension in Swedish primary health care: a QregPV cohort study using explainable machine learning. European heart journal. Cardiovascular pharmacotherapy · 29 Jun 2026 PMID 42366593
- Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study. PLoS medicine · 24 Jun 2026 PMID 42340940
Human data, design not indexed (2)
- Deciphering the Mechanisms of Statin-Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data. CPT: pharmacometrics & systems pharmacology · 1 Sept 2026 PMID 42678094
- Lipid-modifying pharmacotherapy in diabetes mellitus: A protocol for a systematic review and network meta-analysis of randomised trials. PloS one · 23 Jul 2026 PMID 42490696
Preclinical: animal, cell and lab studies (1)
- Targeting cholesterol-dependent Piezo1 activation impairs amoeboid migration in melanoma cells. Proceedings of the National Academy of Sciences of the United States of America · 9 Sept 2026 PMID 42715085
Unclassified: not yet indexed with MeSH (1)
- Statins are associated with decreased risk of disease progression and death in non-cirrhotic patients with primary biliary cholangitis. European journal of internal medicine · 3 Oct 2026 PMID 42829287
Written from 13 PubMed abstracts, each one listed by PMID above. Published: 2026-06-14. Last written: 2026-09-11 by GPT. Drafted by language models from published abstracts; not medical advice.